About Adhya Pharma
Adhya Pharma is a Healthcare company based in India. Pharmaceutical manufacturing and research focused on innovative therapies in Uttarakhand. The company has 48 employees. Its Indian entity Adhya Pharmaceuticals Private Limited reported revenue of ₹14.61 Cr. Adhya Pharma offers products and services including Anti-Cough Medicine and Therapies for Liver Diseases. Its focus areas include Pharmaceuticals, Drug Manufacturing, Therapeutics Development and Medical Research.
Company details
Adhya Pharma is identified as a company that develops innovative therapies aimed at improving outcomes for patients suffering from progressive non-viral liver diseases and other life-threatening conditions. It is dedicated to the discovery, development, and commercialization of treatments, with adherence to ISO and G.M.P. norms being maintained through constant modernization. A manufacturing unit is operated in Roorkee, Uttarakhand, where various drug forms are produced and distributed via a nationwide network. The companys efforts are supported by clinical trials and data management, ensuring products are made available to meet global standards.
- Headquarters India
- Employees 48
- SectorsHealthcare
- Email••••••••
- Legal Name Adhya Pharmaceuticals Pvt. Ltd
- Date of Incorporation 20 Oct, 2003
- Jurisdiction Delhi, India
- Annual Revenue₹14.61 Cr
FY 2024 · -32% YoY
- Net Profit₹13.3 Lakh
FY 2024 · 1% margin
- EBITDA₹49.7 Lakh
FY 2024 · 3% margin
- Employee Count48
Associated legal entities of Adhya Pharma
Adhya Pharma operates through Adhya Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Adhya Pharmaceuticals Private Limited CIN U24239UT2003PTC019597 | Active | 20 Oct 2003 | Roorkee, Uttarakhand | ₹14.6 Cr | 48 | 3 | View details |
Products & Services of Adhya Pharma
Adhya Pharma offers a comprehensive portfolio of products and services, including Anti-Cough Medicine and Therapies for Liver Diseases.
Anti-cough medications are manufactured by Adhya Pharma for the treatment of respiratory conditions
Innovative therapies intended to improve outcomes for patients with progressive non-viral liver diseases are developed by Adhya Pharma
Board of directors of Adhya Pharmaceuticals Private Limited (Adhya Pharma)
Adhya Pharmaceuticals Private Limited is the primary company behind Adhya Pharma. The board of Adhya Pharmaceuticals Private Limited currently have 3 directors; the longest-serving is Kuldeep Singh, appointed in 2003. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Kuldeep Singh DIN 00448028 | Managing Director | 20 Oct 2003 | 23 yrs | Adhya Pharmaceuticals Private Limited |
| Dinesh Bansal DIN 00449290 | Director | 23 Dec 2005 | 20 yrs 10 mo | Adhya Pharmaceuticals Private Limited |
| Pradeep Jain DIN 00448107 | Director | 06 Jan 2006 | 20 yrs 9 mo | Adhya Pharmaceuticals Private Limited |
Financials of Adhya Pharma
Figures of Adhya Pharmaceuticals Private Limited, the primary company behind Adhya Pharma, for FY 2024. Revenue was ₹14.61 Cr (-32% year on year). Net profit was ₹13.3 Lakh (1% margin). EBITDA was ₹49.7 Lakh (3% margin). Revenue has grown at a compounded annual rate of -12% over three years and -4% over five years.
- ₹14.61 CrRevenue · FY 2024 · -32% YoY
- ₹13.3 LakhNet profit · 1% margin
- ₹49.7 LakhEBITDA · 3% margin
- ₹12.5 LakhPaid-up capital
- 48Employees (provident fund records)
- -12%Revenue CAGR, 3 years
- -4%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Adhya Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Adhya Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Adhya Pharma
Adhya Pharma is headquartered in India.
Adhya Pharma has 48 employees.
The primary company behind Adhya Pharma, Adhya Pharmaceuticals Private Limited, reported revenue of ₹14.61 Cr for FY 2024, down 32% year on year.
Adhya Pharma is identified as a company that develops innovative therapies aimed at improving outcomes for patients suffering from progressive non-viral liver diseases and other life-threatening conditions. It is dedicated to the discovery, development, and commercialization of treatments, with adherence to ISO and G.M.P. norms being maintained through constant modernization. A manufacturing unit is operated in Roorkee, Uttarakhand, where various drug forms are produced and distributed via a nationwide network. The companys efforts are supported by clinical trials and data management, ensuring products are made available to meet global standards.
Adhya Pharma offers Anti-Cough Medicine and Therapies for Liver Diseases.
Adhya Pharma operates through Adhya Pharmaceuticals Private Limited.
The legal entities of Adhya Pharma currently have 3 directors, including Kuldeep Singh, Pradeep Jain, Dinesh Bansal.